DPP4 inhibitor reinforces cell junction proteins in mouse model of short bowel syndrome

Study demonstrates that DPP4 inhibitor administration upregulates E-cadherin and occludin expression in a mouse model of short bowel syndrome, potentially strengthening intestinal barrier integrity. By preserving cell junction proteins, DPP4I may reduce bacterial translocation risk in SBS patients through anti-inflammatory mechanisms.